Download FREE Report Sample
Download Free sampleNuclear Medicine/Radiopharmaceutic Market contains market size and forecasts of Nuclear Medicine/Radiopharmaceutic in global, including the following market information:
Global Nuclear Medicine/Radiopharmaceutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nuclear Medicine/Radiopharmaceutic Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Nuclear Medicine/Radiopharmaceutic companies in 2021 (%)
The global Nuclear Medicine/Radiopharmaceutic market was valued at 5062.8 million in 2021 and is projected to reach US$ 8421.9 million by 2028, at a CAGR of 7.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tc-99 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine/Radiopharmaceutic include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly and SIEMENS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nuclear Medicine/Radiopharmaceutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine/Radiopharmaceutic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, by Type, 2021 (%)
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Global Nuclear Medicine/Radiopharmaceutic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, by Application, 2021 (%)
Diagnostic
Therapeutic
Global Nuclear Medicine/Radiopharmaceutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine/Radiopharmaceutic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nuclear Medicine/Radiopharmaceutic revenues share in global market, 2021 (%)
Key companies Nuclear Medicine/Radiopharmaceutic sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Nuclear Medicine/Radiopharmaceutic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
